The Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, has granted AstraZeneca Pharma India permission to import pharmaceutical formulations of new drugs for sale or distribution of oral
Wipro GE Healthcare has launched the Versana Premier R3. This is an AI-enabled ultrasound system designed to enhance...
The Indian pharmaceutical sector is witnessing a major advance. Zydus Lifesciences is launching ANVIMO, a cost-effective substitute for the prevention of Cytomegalovirus (CMV) disease in haematopoietic stem cell transplant (HSCT) and kidney transplan
In anticipation of the mandated registration of clinical research organizations (CROs) starting next month, the Central Drug Regulator has set up the Sugam portal to facilitate online registration of the enterprises.
Glenmark Pharmaceuticals Ltd's share price is trading at Rs 1380.8, up 3.49% on the day as of 12:49 eastern standard time on NSE. The stock has arisen significantly in the past...
India to finalize a report this month on the list of drugs to be switched from prescription-based to OTC status. The subcommittee formed to review...
Senores Pharmaceuticals, based out of Gujarat, signed a memorandum of understanding with Dr Reddy's Laboratories regarding the sale of 14...
AstraZeneca Pharma India Ltd has received the approval from the Central Drugs Standard Control Organisation (CDSCO) to launch and import its cancer treatment Durvalumab (Imfinzi) in India. In a regulatory filing, the company noted that the approval i
Zydus Lifesciences Limited declared its intention to concentrate on creating a vaccine that covers both typhoid and shigellosis.
A total of 39 Indian pharmaceutical firms engaged with over 50 Vietnamese partners, participating in productive discussions at an ‘India-Vietnam Business-to-Business (B2B)’ meeting focused on the pharmaceutical sector...
, CDSCO.jpg)
